Clinical Trial Update: A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to assess safety, tolerability, and immune responses of an investigational vaccine to prevent genital herpes lesions in healthy volunteer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• Investigational vaccine for genital herpes (HSV-2)

Snippet

Sponsor: BioNTech SE | Conditions: Genital Herpes Simplex Type 2 | Phase 1 | Status: ACTIVE_NOT_RECRUITING